Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial
Abstract Background The evidence supporting rifampin combination therapy in prosthetic joint infections (PJI) is limited due to the lack of controlled studies. The aim of this study is to evaluate the effect of adding rifampin to conventional antimicrobial therapy in early staphylococcal PJIs treate...
Main Authors: | Øystein Espeland Karlsen, Pål Borgen, Bjørn Bragnes, Wender Figved, Bjarne Grøgaard, Jonas Rydinge, Lars Sandberg, Finnur Snorrason, Helge Wangen, Eivind Witsøe, Marianne Westberg |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | Journal of Orthopaedic Surgery and Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13018-020-01877-2 |
Similar Items
-
Controversy about the Role of Rifampin in Biofilm Infections: Is It Justified?
by: Nora Renz, et al.
Published: (2021-02-01) -
Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study
by: Borg Leijtens, et al.
Published: (2017-05-01) -
Deranged Haemostasis: Rifampin-Induced Coagulopathy
by: Raghu Tiperneni, et al.
Published: (2022-05-01) -
Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study
by: Greimel F, et al.
Published: (2017-06-01) -
Etymologia: Rifampin
by: Ronnie Henry
Published: (2018-03-01)